JEFFREY LERTDILOK: Open Payments
NPI 1720621071 · CARROLLTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,117 in 28 payments from 12 companies in 2025. Trend: 2023 $343 · 2024 $714 · 2025 $1,117
Food & beverage: $1,117
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $311 |
| Janssen Biotech, Inc. | 6 | $188 |
| TG Therapeutics, Inc. | 2 | $158 |
| Amgen Inc. | 3 | $138 |
| TerSera Therapeutics LLC | 3 | $78 |
| Eisai Inc. | 2 | $66 |
| Alexion Pharmaceuticals, Inc. | 2 | $58 |
| Lundbeck LLC | 1 | $34 |
| ViiV Healthcare Company | 1 | $23 |
| ABBVIE INC. | 1 | $23 |
Products named: FASENRA, BRIUMVI, TREMFYA, EVENITY, Quzyttir, SAPHNELO, Leqembi, ULTOMIRIS.
Industry payments across TX — which companies pay providers there.
